Specialty Care
Clinical Nutrition
Disease States
Clinical Education
About Us

Pentec Health and Lobe Sciences Announce Exclusive Distribution Agreement, Initial Availability of Altemia, First U.S. Medical Food For People with Sickle Cell Disease

Pentec Health, Inc. and Lobe Sciences Ltd. are pleased to announce an exclusive U.S. distribution agreement and the initial availability of Altemia™ – the first medical food in the U.S. designed specifically for children and adults with sickle cell disease (SCD).

Americans with Metabolic Diseases Have Access To Firstplay Dietary Foods and Promin Low-Protein Foods via Exclusive Distribution Agreement With Pentec Health, ZOIA Pharma

People living in the U.S. with metabolic disorders now have access to Firstplay Dietary Foods and Promin low-protein food products through an exclusive U.S. distribution agreement with Pentec Health and ZOIA Pharma.

Committed to Helping Improve the Lives of Individuals Living with Rare Metabolic Disorders

At Pentec Health, we understand the complex challenges that accompany living with Phenylketonuria (PKU). Pentec is committed to helping improve the lives of individuals living with rare metabolic disorders and providing expanded access to both formulas and low-protein Medical Foods for PKU families.

Pentec Health’s Acquisition of ZOIA Pharma Provides People With Phenylketonuria (PKU) Access to the PKU GOLIKE® Family of Medical Food Products

ZOIA Pharma, the only medical food provider in the U.S. focused exclusively on supporting the rare disease community, has been acquired by Pentec Health, Inc. (Pentec), ensuring more people with rare conditions have improved access to a complete range of medical foods.

Market Leader Pentec Health Transforming as Complex Care Provider, Expanding Into Adjacent Underserved Clinical Nutrition, Specialty Care Markets

Pentec Health, Inc., a leading provider of healthcare services for complex care challenges, is transforming into a Complex Care Provider to reflect the expansion of its market-leading expertise into adjacent emerging and underserved areas of clinical nutrition and specialty care.

Pentec Health Names Matthew Deans President and Chief Executive Officer, Continuing Focus on Strategic Growth and Expansion of Patient Care Services and Products to Address Complex Care Needs

Pentec Health Inc., a nationwide leader in providing patient-specific compounded sterile medications and complex in-home clinical services, announced today that Matthew Deans would lead the company as President and Chief Executive Officer, effective April 10.

Pentec Health Inc., Will Be Featured on a Special Episode of “The Balancing Act®” Airing on Lifetime®

The episode will highlight the benefits of Proplete® Intradialytic Parenteral Nutrition (IDPN) and Intraperitoneal Nutrition (IPN) protein therapies for malnourished hemodialysis and peritoneal dialysis patients.

Transitional Care Units in Dialysis

Despite continuous efforts to educate on CKD, many patients starting dialysis in the United States still are not aware of, or understand, dialysis.

Pentec Health welcomes Eric C. Mollman as Chief Financial Officer

Pentec Health Inc., a nationwide leader in providing patient-specific compounded sterile medications and complex in-home clinical services, welcomes Eric C. Mollman, Chief Financial Officer.

Early Signs of Kidney Disease

At Pentec Health it is our duty to serve and educate patients and dietitians in our industry. While there is no true cure for chronic kidney disease, there are ways to cope with, treat, and possibly prevent kidney failure.